These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3158731

  • 1. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites.
    Severson JA, Randall PK.
    J Pharmacol Exp Ther; 1985 May; 233(2):361-8. PubMed ID: 3158731
    [Abstract] [Full Text] [Related]

  • 2. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK.
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [Abstract] [Full Text] [Related]

  • 3. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A.
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [Abstract] [Full Text] [Related]

  • 4. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE, Creese I.
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [Abstract] [Full Text] [Related]

  • 5. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA, Seeman P.
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 7. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT, Matsokis NA, Valcana T.
    J Neurosci Res; 1993 Aug 01; 35(5):499-506. PubMed ID: 8377223
    [Abstract] [Full Text] [Related]

  • 8. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 01; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 9. The interaction between D-2 dopamine receptors and GTP-binding proteins.
    Ohara K, Haga K, Berstein G, Haga T, Ichiyama A, Ohara K.
    Mol Pharmacol; 1988 Mar 01; 33(3):290-6. PubMed ID: 2451115
    [Abstract] [Full Text] [Related]

  • 10. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
    Seeman P, Tallerico T, Ko F, Tenn C, Kapur S.
    Synapse; 2002 Dec 15; 46(4):235-9. PubMed ID: 12373738
    [Abstract] [Full Text] [Related]

  • 11. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE, Hamblin MW, Creese I.
    Mol Pharmacol; 1985 Feb 15; 27(2):171-83. PubMed ID: 3969066
    [Abstract] [Full Text] [Related]

  • 12. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
    Creese I, Sibley DR, Leff SE.
    Fed Proc; 1984 Oct 15; 43(13):2779-84. PubMed ID: 6383871
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
    Rogue P, Zwiller J, Malviya AN, Vincendon G.
    Biochem Int; 1990 Nov 15; 22(3):575-82. PubMed ID: 1981673
    [Abstract] [Full Text] [Related]

  • 14. Age-related changes in the human nigrostriatal dopaminergic system.
    De Keyser J, Ebinger G, Vauquelin G.
    Ann Neurol; 1990 Feb 15; 27(2):157-61. PubMed ID: 2107785
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V.
    J Neural Transm Suppl; 1983 Feb 15; 18():165-79. PubMed ID: 6192208
    [Abstract] [Full Text] [Related]

  • 16. Interactions between the dopamine D2 receptor and GTP-binding proteins.
    Plug MJ, Möller W, Dijk J.
    Biochem Int; 1992 Oct 15; 28(1):21-9. PubMed ID: 1445393
    [Abstract] [Full Text] [Related]

  • 17. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR, Molinoff PB.
    Mol Pharmacol; 1983 Mar 15; 23(2):303-9. PubMed ID: 6835199
    [Abstract] [Full Text] [Related]

  • 18. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    Hamblin MW, Creese I.
    Mol Pharmacol; 1982 Jan 15; 21(1):52-6. PubMed ID: 7132962
    [Abstract] [Full Text] [Related]

  • 19. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.
    Boundy VA, Lu L, Molinoff PB.
    J Pharmacol Exp Ther; 1996 Feb 15; 276(2):784-94. PubMed ID: 8632351
    [Abstract] [Full Text] [Related]

  • 20. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL, Krstich M, Beart PM.
    Brain Res; 1983 Nov 14; 278(1-2):155-63. PubMed ID: 6227373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.